Showing results (301-310 of 330) with videos related to
Sort By:
Pageof 33
The Journal of Urology|April 1, 1988
Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomyJ E Oesterling, D W Chan, J I Epstein, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 1998
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasiaJ D Brooks, M Weinstein, X Lin, et al.Urology|October 1, 1996
Histopathologic characterization of hereditary benign prostatic hyperplasiaC B Doehring, M G Sanda, A W Partin, et al.Journal of Cancer Research and Clinical Oncology|April 9, 2008
Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarraysM Burchardt, R Engers, M Müller, et al.Urology|May 1, 1995
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomyA W Partin, S Piantadosi, M G Sanda, et al.European Urology|March 18, 2000
Genetic alterations in urinary bladder carcinosarcoma: evidence of a common clonal originS Halachmi, A M DeMarzo, N H Chow, et al.Human Pathology|December 1, 2001
Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinomaN Rioux-Leclercq, J I Epstein, J Y Bansard, et al.The New England Journal of Medicine|September 6, 1990
Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trialM D Rifkin, E A Zerhouni, C A Gatsonis, et al.Biochemical and Biophysical Research Communications|January 14, 1994
Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancerM P Schoenberg, J M Hakimi, S Wang, et al.Urology|December 1, 1996
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancerJ Pannek, E N Subong, K A Jones, et al.Pageof 33